BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35655041)

  • 1. Establishment and characterization of NCC-SS5-C1: a novel patient-derived cell line of synovial sarcoma.
    Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Akiyama T; Sugaya J; Kojima N; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2022 Jul; 35(4):1290-1297. PubMed ID: 35655041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of NCC-SS3-C1: a novel patient-derived cell line of synovial sarcoma.
    Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Sugaya J; Iwata S; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2020 Jul; 33(3):877-885. PubMed ID: 32274656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of NCC-SS4-C1: a novel patient-derived cell line of synovial sarcoma.
    Tsuchiya R; Yoshimatsu Y; Noguchi R; Ono T; Sei A; Takeshita F; Sugaya J; Iwata S; Yoshida A; Ohtori S; Kawai A; Kondo T
    Hum Cell; 2021 May; 34(3):998-1007. PubMed ID: 33611700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line.
    Kito F; Oyama R; Takai Y; Sakumoto M; Shiozawa K; Qiao Z; Uehara T; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2018 Apr; 31(2):167-174. PubMed ID: 29450702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1.
    Oyama R; Kito F; Sakumoto M; Shiozawa K; Toki S; Endo M; Yoshida A; Kawai A; Kondo T
    In Vitro Cell Dev Biol Anim; 2018 May; 54(5):392-399. PubMed ID: 29626278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
    Carmody Soni EE; Schlottman S; Erkizan HV; Uren A; Toretsky JA
    Clin Orthop Relat Res; 2014 Mar; 472(3):874-82. PubMed ID: 23716114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma.
    Yoshimatsu Y; Noguchi R; Tsuchiya R; Kito F; Sei A; Sugaya J; Nakagawa M; Yoshida A; Iwata S; Kawai A; Kondo T
    Hum Cell; 2020 Apr; 33(2):427-436. PubMed ID: 31898195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo.
    Takenaka S; Naka N; Araki N; Hashimoto N; Ueda T; Yoshioka K; Yoshikawa H; Itoh K
    Int J Oncol; 2010 Apr; 36(4):823-31. PubMed ID: 20198325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary pulmonary synovial sarcoma: A reappraisal.
    Panigrahi MK; Pradhan G; Sahoo N; Mishra P; Patra S; Mohapatra PR
    J Cancer Res Ther; 2018; 14(3):481-489. PubMed ID: 29893303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histology and grading are important prognostic factors in synovial sarcoma.
    Bianchi G; Sambri A; Righi A; Dei Tos AP; Picci P; Donati D
    Eur J Surg Oncol; 2017 Sep; 43(9):1733-1739. PubMed ID: 28579008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of NCC-MFS6-C1: a novel patient-derived cell line of myxofibrosarcoma.
    Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Akiyama T; Sato C; Kobayashi E; Kojima N; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2022 Nov; 35(6):1993-2001. PubMed ID: 35947340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of NCC-PS1-C1: a novel cell line of pleomorphic sarcoma from a patient after neoadjuvant radiotherapy.
    Akiyama T; Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Sugaya J; Kobayashi E; Yoshida A; Ohtori S; Kawai A; Kondo T
    Hum Cell; 2022 Nov; 35(6):2011-2019. PubMed ID: 36103079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier.
    Tamaki S; Fukuta M; Sekiguchi K; Jin Y; Nagata S; Hayakawa K; Hineno S; Okamoto T; Watanabe M; Woltjen K; Ikeya M; Kato T; Toguchida J
    PLoS One; 2015; 10(11):e0142991. PubMed ID: 26571495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases.
    Przybyl J; Sciot R; Rutkowski P; Siedlecki JA; Vanspauwen V; Samson I; Debiec-Rychter M
    Tumour Biol; 2012 Dec; 33(6):2245-53. PubMed ID: 22976541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of NCC-UPS4-C1: a novel cell line of undifferentiated pleomorphic sarcoma from a patient with Li-Fraumeni syndrome.
    Ono T; Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Akiyama T; Sugaya J; Fukushima S; Kojima N; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2022 Mar; 35(2):756-766. PubMed ID: 35118583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and characterization of a novel patient-derived Ewing sarcoma cell line, NCC-ES2-C1.
    Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Akiyama T; Nakagawa R; Kamio S; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
    Hum Cell; 2022 Jul; 35(4):1262-1269. PubMed ID: 35441357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein.
    Yoneda Y; Ito S; Kunisada T; Morimoto Y; Kanzaki H; Yoshida A; Shimizu K; Ozaki T; Ouchida M
    PLoS One; 2013; 8(10):e77564. PubMed ID: 24130893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.
    Peng C; Zhao H; Chen W; Song Y; Wang X; Li J; Qiao Y; Wu D; Ma S; Wang X; Gao C
    Oncotarget; 2016 Oct; 7(41):66822-66834. PubMed ID: 27572315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SYT-SSX1 enhances the invasiveness and maintains stem-like cell properties in synovial sarcoma via induction of TGF-β1/Smad signaling.
    Qi Y; Dong SS; He YL; Liu ZH; Huang YL; Wang N; Zhang Z; Li Z; Shi METHTM; Feng X; Yao Q; Zou H; Hu JM; Pang LJ; Li F
    BMC Cancer; 2022 Feb; 22(1):166. PubMed ID: 35151264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First cloned human immortalized adipose derived mesenchymal stem-cell line with chimeric SS18-SSX1 gene (SS-iASC).
    Mihály D; Matula Z; Changchien YC; Papp G; Tátrai P; Sápi Z
    Cancer Genet; 2017 Oct; 216-217():52-60. PubMed ID: 29025595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.